Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
BLTE
Stock Latest News
The Fly
Belite Bio management to meet with Piper Sandler
13h ago
BLTE
Premium
The Fly
Belite Bio price target raised to $234 from $220 at Mizuho
24d ago
BLTE
Premium
The Fly
Belite Bio price target raised to $245 from $214 at H.C. Wainwright
25d ago
BLTE
Premium
Company Announcements
Belite Bio Files Sakigake-Backed Tinlarebant NDA in Japan for Stargardt Disease
25d ago
6K
BLTE
Premium
The Fly
Belite Bio submits NDA to MHLW in Japan for tinlarebant in STGD1
25d ago
BLTE
Premium
The Fly
UiPath downgraded, Shell upgraded: Wall Street’s top analyst calls
29d ago
LEN
ORA
Premium
The Fly
Canaccord starts Belite Bio at Buy on additional post-IPO upside
29d ago
BLTE
Premium
The Fly
Belite Bio initiated with a Buy at Canaccord
29d ago
BLTE
Premium
Company Announcements
Belite Bio Earnings Call Highlights Tinlarebant Momentum
1M ago
BLTE
Premium
The Fly
Belite Bio price target raised to $206 from $201 at Morgan Stanley
2M ago
BLTE
Premium
The Fly
Belite Bio announces FDA acceptance, priority review of tinlarebant NDA
2M ago
BLTE
Premium
The Fly
Belite Bio price target raised to $214 from $200 at H.C. Wainwright
2M ago
BLTE
Premium
The Fly
Belite Bio reports Q2 EPS (54c), consensus (78c)
2M ago
BLTE
Premium
The Fly
Morning Movers: Cerebras slides following quarterly results
2M ago
GO
JD
Premium
The Fly
Belite Bio price target raised to $220 from $215 at Mizuho
2M ago
BLTE
Premium
The Fly
Belite Bio price target raised to $270 from $266 at Cantor Fitzgerald
2M ago
BLTE
Premium
The Fly
Belite Bio price target raised to $206 from $201 at Morgan Stanley
2M ago
BLTE
Premium
Company Announcements
Belite Bio Gains FDA Priority Review for Tinlarebant as Losses Widen on Commercial Build-Out
2M ago
6K
BLTE
Premium
Ratings
Yi Chen Raises Approval Odds and Lifts Tinlarebant-Focused 12‑Month Price Target to $214 While Reiterating Buy Rating
2M ago
BLTE
Premium
Company Announcements
Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease
2M ago
6K
BLTE
Premium
Pre-Earnings
BLTE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
BLTE
Premium
The Fly
Belite Bio completes rolling submission of NDA to U.S. FDA for tinlarebant
4M ago
BLTE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
